Eculizumab for Treatment of Refractory Thymomatous Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis (P7-11.031)
To describe the role of eculizumab for treatment of refractory thymomatous Acetylcholine receptor antibody positive generalized Myasthenia Gravis (AChR+gMG) with frequent exacerbations.
Authors
- Lauren Williams
- Nakul Katyal (ORCID: https://orcid.org/0000-0003-0249-1707)
- Divya Menghani
Institutions
- University of Kentucky (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211221
- Citations
- 1
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 1.39